These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38603859)

  • 1. The association between expression of CD200 on B lymphocytes and the count of eosinophils and basophils in atopic dermatitis patients with and without dupilumab therapy - Pilot study.
    Čelakovská J; Čermákova E; Boudková P; Andrýs C; Krejsek J
    Int Immunopharmacol; 2024 May; 132():112023. PubMed ID: 38603859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between eosinophils (CD16
    Čelakovská J; Čermáková E; Boudková P; Andrýs C; Krejsek J
    Dermatol Ther (Heidelb); 2023 May; 13(5):1193-1210. PubMed ID: 37071375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Leukocytes, B and T Lymphocytes, and expression of CD200 and CD23 on B lymphocytes in Patients with Atopic Dermatitis on Dupilumab Therapy-Pilot Study.
    Čelakovská J; Čermáková E; Boudková P; Andrýs C; Krejsek J
    Dermatol Ther (Heidelb); 2023 May; 13(5):1171-1192. PubMed ID: 37097547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in immunological profile in atopic dermatitis patients with and without dupilumab therapy.
    Čelakovská J; Čermáková E; Boudková P; Andýs C; Krejsek J
    Immunol Med; 2024 Aug; ():1-14. PubMed ID: 39148480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological Parameters in Patients Suffering from Atopic Dermatitis and Either Treated or Non-Treated with Dupilumab.
    Boudková P; Čelakovská J; Čermáková E; Andrýs C; Krejsek J
    Acta Medica (Hradec Kralove); 2023; 66(2):47-54. PubMed ID: 37930093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between the level of specific IgE to molecular components of mites and the expression of CD23 molecule on B lymphocytes in atopic dermatitis patients treated or not treated with dupilumab-Pilot study.
    Čelakovská J; Čermáková E; Boudková P; Andrýs C; Krejsek J
    Clin Transl Allergy; 2023 Jul; 13(7):e12278. PubMed ID: 37488727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between NK cells and ILC cells and their subsets in atopic dermatitis patients with and without dupilumab therapy.
    Boudkova P; Čermáková E; Krejsek J; Čelakovská J
    Int Immunopharmacol; 2024 Jul; 136():112327. PubMed ID: 38820963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient Increase in Circulating Basophils and Eosinophils in Dupilumab-associated Conjunctivitis in Patients with Atopic Dermatitis.
    Katsuta M; Ishiuji Y; Matsuzaki H; Yasuda KI; Kharma B; Nobeyama Y; Hayashi T; Tokura Y; Asahina A
    Acta Derm Venereol; 2021 Jun; 101(6):adv00483. PubMed ID: 34043018
    [No Abstract]   [Full Text] [Related]  

  • 9. Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab.
    Mizuno M; Horiguchi G; Teramukai S; Ichiyama S; Ito M; Hoashi T; Kanda N; Saeki H
    Australas J Dermatol; 2021 Nov; 62(4):e504-e509. PubMed ID: 34523731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis.
    Bakker DS; van der Wal MM; Heeb LEM; Giovannone B; Asamoah M; Delemarre EM; Drylewicz J; Nierkens S; Boyman O; de Bruin-Weller MS; Thijs JL; van Wijk F
    J Invest Dermatol; 2021 Aug; 141(8):1943-1953.e13. PubMed ID: 33610558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations.
    Sihra BS; Kon OM; Grant JA; Kay AB
    J Allergy Clin Immunol; 1997 May; 99(5):699-706. PubMed ID: 9155838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
    Raffi J; Suresh R; Botto N; Murase JE
    J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease.
    Ferrucci S; Angileri L; Tavecchio S; Fumagalli S; Iurlo A; Cattaneo D; Marzano AV; Maronese CA
    J Dermatolog Treat; 2022 Aug; 33(5):2587-2592. PubMed ID: 35261333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation.
    Jiao D; Wong CK; Qiu HN; Dong J; Cai Z; Chu M; Hon KL; Tsang MS; Lam CW
    Cell Mol Immunol; 2016 Jul; 13(4):535-50. PubMed ID: 26388234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of eosinophils, basophils, serum total IgE level, allergen-specific IgE, and clinical features in atopic dermatitis.
    Hu Y; Liu S; Liu P; Mu Z; Zhang J
    J Clin Lab Anal; 2020 Jun; 34(6):e23214. PubMed ID: 32068307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy.
    Čelakovská J; Čermáková E; Andrýs C; Boudkova P; Krejsek J
    J Dermatolog Treat; 2024 Dec; 35(1):2305832. PubMed ID: 38263709
    [No Abstract]   [Full Text] [Related]  

  • 17. Bidirectional associations between eosinophils, basophils, and lymphocytes with atopic dermatitis: A multivariable Mendelian randomization study.
    Zeng-Yun-Ou Z; Zhong-Yu J; Wei L
    Front Immunol; 2022; 13():1001911. PubMed ID: 36569933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab as Therapeutic Option in Polysensitized Atopic Dermatitis Patients Suffering from Food Allergy.
    Sernicola A; Amore E; Rizzuto G; Rallo A; Greco ME; Battilotti C; Svara F; Azzella G; Nisticò SP; Dattola A; Chello C; Pellacani G; Grieco T
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.
    Nakahara T; Izuhara K; Onozuka D; Nunomura S; Tamagawa-Mineoka R; Masuda K; Ichiyama S; Saeki H; Kabata Y; Abe R; Ohtsuki M; Kamiya K; Okano T; Miyagaki T; Ishiuji Y; Asahina A; Kawasaki H; Tanese K; Mitsui H; Kawamura T; Takeichi T; Akiyama M; Nishida E; Morita A; Tonomura K; Nakagawa Y; Sugawara K; Tateishi C; Kataoka Y; Fujimoto R; Kaneko S; Morita E; Tanaka A; Hide M; Aoki N; Sano S; Matsuda-Hirose H; Hatano Y; Takenaka M; Murota H; Katoh N; Furue M
    Medicine (Baltimore); 2020 Sep; 99(38):e22043. PubMed ID: 32957324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Short Cycle of Narrow-Band UVB Phototherapy in the Early Phase of Dupilumab Therapy Can Provide a Quicker Improvement of Severe Atopic Dermatitis.
    Rossi M; Rovati C; Arisi M; Tomasi C; Calzavara-Pinton I; Venturini M; Calzavara-Pinton P
    Dermatology; 2021; 237(3):407-415. PubMed ID: 33401279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.